Place of oligopeptide H-Met-Glu-His-Phe-Pro-Gly-Pro-OH in the therapy and rehabilitation of patients with ischemic stroke

Cerebrovascular diseases (CVDs) are one of the leading causes of death and disability In Russia: they rank second in the structure of mortality from diseases of the circulatory system and in the overall mortality of the population. Successful treatment of CVD involves an integrated approach to the p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova Jg. 124; H. 8. Vyp. 2; S. 56
Hauptverfasser:	Spirin, N N, Fedorov, V N, Vdovichenko, V P
Format:	Journal Article
Sprache:	Russisch
Veröffentlicht:	Russia (Federation) 2024
Schlagworte:	Administration, Intranasal Humans Ischemic Stroke - drug therapy Neuroprotective Agents - administration & dosage Neuroprotective Agents - therapeutic use Oligopeptides - therapeutic use Stroke Rehabilitation - methods cerebrovascular diseases oligopeptide H-Met-Glu-His-Phe-Pro-Gly-Pro-OH ischemic stroke neuroprotectors
ISSN:	1997-7298
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!